Feel Comfortable Not Giving Alirocumab During Hospitalization
Alirocumab (Praluent, PRAL-you-ent) is the first "PCSK9 inhibitor" for high cholesterol.
It works by preventing PCSK9...proprotein convertase subtilisin kexin type 9...from binding and degrading liver LDL receptors. This leads to more LDL receptors...and more LDL cholesterol clearing from the blood.
Alirocumab can lower LDL by about 60%, regardless of statin use.